Product
IMC-F106C and Pembrolizumab
Aliases
IMC-F106C, IMC-F106C and pembrolizumab
Name
IMC-F106C
1 clinical trial
2 drugs
1 indication
Indication
solid tumorsDrug
IMC-F106CDrug
AdagrasibClinical trial
Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive CancersStatus: Recruiting, Estimated PCD: 2026-06-01